![]() |
Cover illustration: Aqua(benzo-15-crown-5)lithium--hexa-mu-iodotetracopper--benzo-15-crown-5 (2/1/2), bis\[bis(benzo-15-crown-5)caesium\] hexa-mu-iodotetracopper and mu-aqua-bis\[aqua(18-crown-6)sodium\] hexa-mu-iodotetracopper, see Nurtaeva & Holt, pages 1453-1457. Displacement ellipsoids are shown at the 50% probability level. |
Acta Cryst. (1999). C55, IUC9900099 [ doi:10.1107/S0108270199098935 ]
Synopsis: Hydrothermally grown single crystals of the title compound, Na2ZnGeO4, are monoclinic [space group Pn (No.7)]. The structure is confirmed; recognition of the true monoclinic symmetry with pseudo-orthorhombic twinning enabled refinement to R = 0.022 from data measured at 150K.
Formula: Na2ZnGeO4
Acta Cryst. (1999). C55, IUC9900098 [ doi:10.1107/S0108270199098923 ]
Synopsis: The Sn atom in 2,2'-iminodipyridinium(1+) dichlorotriphenylstannate, (C10H10N3)[SnCl2(C6H5)3], shows trans-C3SnCl2 trigonal-bipyramidal coordination. The stannate anion is linked by hydrogen bonds to adjacent counter-ions to form a chain. 2,2'-Iminodipyridinium(1+) bis(trifluoroacetato)tricyclohexylstannate, (C10H10N3)[Sn(C2F3O2)(C6H11)3], adopts a similar hydrogen-bonded chain structure.
Formula: (C10H10N3)[SnCl2(C6H5)3] and (C10H10N3)[Sn(C2F3O2)(C6H11)3]
Acta Cryst. (1999). C55, IUC9900103 [ doi:10.1107/S0108270199098911 ]
Synopsis: In the crystal structure of the title compound, the Rh atom lies on an inversion centre and has a square-planar geometry with Rh-P = 2.3217(6), Rh-C = 1.954(2)Å and P-Rh-C = 86.74(7)°. The carborane anion lies about a twofold axis and is disordered.
Formula: [Rh(C5H9N)2(C18H15P)2](C2H12B9)
Acta Cryst. (1999). C55, IUC9900106 [ doi:10.1107/S010827019909890X ]
4C,2
4C-
-dicyclohexylphosphido-1:2
2P:P-triphenylphosphine-2
P-silverdirhenium(2
Re--Ag)Synopsis: The title compound shows a nearly planar PRe2Ag ring with significantly different Re-Ag single-bond lengths of 2.7957(7) and 2.8235(7)Å.
Formula: [Re2Ag(C12H22P)(C18H15P)(CO)8]
Acta Cryst. (1999). C55, IUC9900107 [ doi:10.1107/S0108270199098893 ]
Synopsis: In the structure of the title complex, [CuBr(phen)(PPh3)], the coordination polyhedron with copper as the central atom is a distorted tetrahedron, with two N atoms of phenathroline, one Br atom and one P atom of PPh3 occupying the four corners.
Formula: [CuBr(C12H8N2)(C18H15P)]
Acta Cryst. (1999). C55, IUC9900108 [ doi:10.1107/S0108270199098881 ]
Synopsis: The structure of the title compound, bis(2,2'-bipyridine-N,N')(pyridine-2-carboxylate-N,O)ruthenium( II) hexafluorophosphate, determined at 173K, is in good agreement with the structure determined at 295K [Canty et al. (1997). Inorg. Chim. Acta, 255, 117-123]. The coordination formed by five N atoms and one O atom around the RuII ion deviates substantially from octahedral symmetry. The relatively large thermal parameters of the F atoms in the PF6 anion can be assumed as being due to substantial rigid group vibrations.
Formula: [Ru(C6H4O2)(C10H8N2)2]PF6
Acta Cryst. (1999). C55, IUC9900104 [ doi:10.1107/S010827019909887X ]
Synopsis: Domperidone maleate or 4-[5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl]-1-[(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]piperidinium maleate, an antiemetic drug, crystallizes as a 2.5-hydrate. The hydrogen-bonding interactions between the drug molecule, the maleate group and the water molecules stabilize the molecules in the lattice. Further stability comes from stacking interactions among the benzimidazole rings.
Formula: C22H25ClN5O2+C4H3O4-2.5H2O
Acta Cryst. (1999). C55, IUC9900105 [ doi:10.1107/S0108270199098868 ]
,17
-androstane-17-carboxamide methanol solvate, a finasteride impuritySynopsis: The title compound was isolated during impurity profiling of the drug finasteride. This molecule is a saturated form of finasteride where the A/B ring junction is cis. The compound is a methanol solvate and there are hydrogen-bonding interactions between the androstane and methanol solvate molecules.
Formula: C23H38N2O2CH4O
Acta Cryst. (1999). C55, IUC9900100 [ doi:10.1107/S0108270199098856 ]
Synopsis: Initiation and progress of the majority of breast cancer cases are influenced by a family of hormones called estrogens. Estradiol is one of the three naturally occurring estrogens. This submission reports estradiol in a previously unknown crystal modification as the methanol hemisolvate.
Formula: C18H24O20.5CH4O
Acta Cryst. (1999). C55, IUC9900101 [ doi:10.1107/S0108270199098844 ]
Synopsis: In the title compound, each I atom is situated 3.80Å from the ring centroid of a nearby pyridium ring, with shortest iodide contacts to that ring in the range 4.02-4.05Å. The closest contacts from iodide to the dication are in the range 3.77-4.05Å, with shortest distances to the N and ortho-C atoms of 3.843(3) and 3.770(4)Å, respectively.
Formula: C14H18N22+2I-
Acta Cryst. (1999). C55, IUC9900102 [ doi:10.1107/S0108270199098832 ]
Synopsis: The title compound is a stable radical with the piperidine ring adopting a chair conformation. The nitroxyl bond length is 1.283(2)Å and the N-O. bond forms an angle of 19.9 (2)° with the CNC plane; the C-N-C angle is 124.5 (2)°.
Formula: C10H20NO4S
Acta Cryst. (1999). C55, IUC9900110 [ doi:10.1107/S0108270199098820 ]
Synopsis: The title compound is a tricyclic polyfunctional system bearing an aromatic ring with a chlorine and a methylmalonate substituent, and a bicyclo[3.3.2]decane subunit with another chlorine and an enone functionality.
Formula: C20H20Cl2O5
Acta Cryst. (1999). C55, IUC9900109 [ doi:10.1107/S0108270199098819 ]
Synopsis: The structure of the title compound, [(CH3)3CNH2NH2]Cl, first determined by Hökelek & Yagbasen [Acta Cryst. (1988), C44, 723-725], has been redetermined. In contrast to the previous investigation, no hydrochloride moiety was found. The present structure consists of [(CH3)3C(NH2)(NH2)]+ cations and Cl- anions connected by hydrogen bonds.
Formula: C4H13N2+Cl-
Acta Cryst. (1999). C55, IUC9900111 [ doi:10.1107/S0108270199098807 ]
,3'b
,6'a
,7'a
)- and (±)-(3'a
,3'b
,6'a
,7'a
)-2,3,3a,3b,4,5,6,6a,7,7a-decahydro-5,5-dimethylspiro[1,3-dioxane-2,5'-pentaleno[2,1-b]furan]-2'-oneSynopsis: The crystal structures of the title compounds, (±)-(3'a
,3'b
,-6'a
,7'a
)-, (I), and (±)-(3'a
,3'b
,6'a
,7'a
)-, (II), have been determined at 134 and 135 K,
respectively. The pentaleno[2,1-b]furan group has an endo conformation in (I) and an exo conformation in
(II). The axial C-C bond attached to the spiro center is about 0.02Å longer than the equatorial C-C bond.
Formula: C15H22O4 and C15H22O4
Acta Cryst. (1999). C55, 1381-1383 [ doi:10.1107/S0108270199007477 ]
-cyano)dicuprate(I)copper(II)Synopsis: The crystal structure of the title mixed-valence copper-cyanide complex comprises infinite polymeric double chains. The geometry about the CuI centres is approximately trigonal pyramidal, and each CuII centre adopts a slightly distorted square-pyramidal coordination, with one NH3 ligand being disordered equally over two alternative sites.
Formula: [Cu3(CN)4(NH3)3]
Acta Cryst. (1999). C55, 1383-1384 [ doi:10.1107/S0108270199007805 ]
-(Co0.7Fe0.3)MoO4Synopsis: The crystal structure of the mixed transition-metal molybdate
-AMoO4, with A = 30% Fe and 70% Co, is built up from AO6 octahedra and
MoO4 tetrahedra. The Fe and Co distribution is different for the two A sites.
Formula: Co0.7Fe0.3MoO4
Acta Cryst. (1999). C55, 1384-1388 [ doi:10.1107/S0108270199007799 ]
''-aluminogallateSynopsis: The title compound is a non-stoichiometric ionic conductor with the chemical formula K1.67Mg0.67(Al10.33-xGax)O17, where x = 1.75. This corresponds to a 17% gallium substitution of the aluminium spinel block framework. The gallium substitution influences the mobile K+ ion distribution and hence the ion conductivity.
Formula: K1.67Mg0.67Al8.58Ga1.75O17
Acta Cryst. (1999). C55, 1388-1391 [ doi:10.1107/S0108270199006265 ]
Synopsis: The polyanion chain, extending along the b direction, is formed by MgO6 octahedra sharing O atoms from different paradodecatungstate groups.
Formula: (NH4)2[Mg4(H2O)18(H2W12O42)]10H2O
Acta Cryst. (1999). C55, 1391-1393 [ doi:10.1107/S0108270199005144 ]
Synopsis: The title compound, potassium niobium aluminium arsenate (KNAA), is isostructural with KTiOPO4 (KTP). In KNAA, the site corresponding to the Ti1 sites of KTP is occupied mostly by Nb atoms, the Ti2 site is occupied predominantly by Al atoms, and the As1 and As2 tetrahedral sites are occupied mostly by As atoms.
Formula: K2NbAlO2[(As0.8Nb0.2)O4]2
Acta Cryst. (1999). C55, 1393-1395 [ doi:10.1107/S0108270199007623 ]
Synopsis: The title non-linear optical material has tetrahedral Zn and Cd atoms connected in a three-dimensional network by Cd-S=C=N-Zn bridges which are linear at C and N, but bent at S.
Formula: ZnCd(SCN)4
Acta Cryst. (1999). C55, 1395-1398 [ doi:10.1107/S0108270199003637 ]
et
![[bold gamma]](/logos/entities/gamma_bdgif.gif)
Synopsis: The structure of
-Sr(PO3)2
consists of (Sr4O22)n double chains and infinite
(PO3)n polyphosphate chains linked together by sharing edges and corners. The structure of
-Sr(PO3)2 has been redetermined.
Formula: beta- et gamma-Sr(PO3)2
Acta Cryst. (1999). C55, 1398-1399 [ doi:10.1107/S010827019900637X ]
Synopsis: The title compound is built up from ZnO6 octahedra, SeO3 pyramids and NaO4 tetrahedra, sharing vertices and edges. It is iso- structural with NaCo2(OH)(SeO3)2.
Formula: NaZn2(OH)(SeO3)2
Acta Cryst. (1999). C55, 1400-1401 [ doi:10.1107/S0108270199007568 ]
Synopsis: Dibarium gallium hydrogen bis(diphosphate) was synthesized by high temperature-pressure hydrothermal reaction. The structure consists of infinite chains of corner-sharing GaO6 octahedra and H0.5P2O7 groups, which are topologically similar to that found in Cs2GaH3(P2O7)2.
Formula: Ba2GaH(P2O7)2
Acta Cryst. (1999). C55, 1402-1403 [ doi:10.1107/S0108270199006423 ]
Formula: [Cu(C12H22N4)2]PF6
Acta Cryst. (1999). C55, 1404-1406 [ doi:10.1107/S0108270199007817 ]
Formula: [PdCl(C14H30N4)]Cl2H2O
Acta Cryst. (1999). C55, 1406-1408 [ doi:10.1107/S0108270199007490 ]
Formula: [Pt(C2H2N)2(C18H15P)2]0.6CH2Cl2
Acta Cryst. (1999). C55, 1408-1410 [ doi:10.1107/S010827019900757X ]
Formula: [Pt(C8H7O3)2(C18H15P)2]CH2Cl2
Acta Cryst. (1999). C55, 1410-1411 [ doi:10.1107/S010827019900699X ]
Formula: [Ni(C6H6NOS)2]
Acta Cryst. (1999). C55, 1412-1413 [ doi:10.1107/S0108270199008197 ]
Formula: [Ag(C19H15N5)(C18H15P)2]ClO4
Acta Cryst. (1999). C55, 1413-1416 [ doi:10.1107/S0108270199006447 ]
Formula: [Cu(C6H2Cl3O)2(NH3)2]
Acta Cryst. (1999). C55, 1416-1418 [ doi:10.1107/S0108270199007076 ]
-N,N'-Bis(salicylidene)-1,3-propanediaminato]-copper(II)}dichloromercury(II)Formula: [CuHgCl2(C17H16N2O2)]
Acta Cryst. (1999). C55, 1418-1420 [ doi:10.1107/S0108270199008057 ]
Formula: (NH4)[Sc(C10H12N2O8)(H2O)2)]3H2O
Acta Cryst. (1999). C55, 1420-1422 [ doi:10.1107/S0108270199007696 ]
-(3-cyanobenzoato-O:O')]Formula: [Er(C8H4NO2)3(H2O)2]
Acta Cryst. (1999). C55, 1422-1425 [ doi:10.1107/S0108270199006836 ]
-chloro-bis[dichlorocuprate(II)] bis(tetrafluoroborate)Formula: (C10H10N2S2)2[Cu2Cl6](BF4)2
Acta Cryst. (1999). C55, 1425-1427 [ doi:10.1107/S0108270199004588 ]
Formula: [Ni(C21H21Cl4N3O2)(C4H8O2)]
Acta Cryst. (1999). C55, 1427-1429 [ doi:10.1107/S010827019900743X ]
-alaninato)tinFormula: [Sn(C4H9)3(C7H6NO4)]
Acta Cryst. (1999). C55, 1429-1431 [ doi:10.1107/S0108270199007180 ]
Formula: [Sn(CH3)3(C9H10NO4S)]
Acta Cryst. (1999). C55, 1431-1434 [ doi:10.1107/S0108270199006988 ]
Formula: [Cu2(C11H11NO3)2(C3H4N2)2]2C3H4N2
Acta Cryst. (1999). C55, 1434-1436 [ doi:10.1107/S0108270199008215 ]
Formula: [La(NO3)3(C15H30N2O3)2]
Acta Cryst. (1999). C55, 1436-1438 [ doi:10.1107/S010827019900760X ]
-2,2',2''-nitrilotriethanethiolato(2 -)-N,S,S':S']dinickel(II)Formula: [Ni2(C6H13NS3)2]
Acta Cryst. (1999). C55, 1438-1440 [ doi:10.1107/S0108270199006733 ]
Formula: [Co(C7H5O3)2(C6H6N2O)2(H2O)2]
Acta Cryst. (1999). C55, 1440-1443 [ doi:10.1107/S0108270199007647 ]
Formula: [Fe(C14H18N3OS)Cl2]C2H6O
Acta Cryst. (1999). C55, 1443-1447 [ doi:10.1107/S0108270199008264 ]
Formula: (C5H14N3)[SbCl4] at 295 and 92 K
Acta Cryst. (1999). C55, 1447-1449 [ doi:10.1107/S0108270199007295 ]
Formula: (C12H24N)2[Sn(C4H9)3(C6H6NO6)]
Acta Cryst. (1999). C55, 1449-1451 [ doi:10.1107/S0108270199007532 ]
-Oxo-bis[mer-trichlorobis(tetrahydrofuran-O)zirconium(IV)]Formula: [Zr2Cl6O(C4H8O)4]
Acta Cryst. (1999). C55, 1451-1453 [ doi:10.1107/S0108270199006551 ]
Formula: [VO(C30H24N2O4)]
Acta Cryst. (1999). C55, 1453-1457 [ doi:10.1107/S0108270199007040 ]
-iodotetracopper-benzo-15-crown-5 (2/1/2), bis[bis(benzo-15-crown-5)caesium] hexa-
-iodotetracopper and
-aqua-bis[aqua(18-crown-6)sodium] hexa-
-iodotetracopperFormula: [Li(C14H20O5)(H2O)]2[Cu4I6]2C14H20O5, [Cs(C14H20O5)2]2[Cu4I6] and [Na2(C12H24O6)2(H2O)3][Cu4I6]
Acta Cryst. (1999). C55, 1457-1460 [ doi:10.1107/S0108270199007982 ]
-(sulfato-O:O')] hydrate]Formula: [Cd(C10H8N2)(H2O)4]SO4 and [Cd(SO4)(C10H8N2)(H2O)2]H2O
Acta Cryst. (1999). C55, 1461-1463 [ doi:10.1107/S0108270199007866 ]
Formula: [PdI(C5H3ClN)(C18H15P)2]
Acta Cryst. (1999). C55, 1463-1466 [ doi:10.1107/S0108270198017508 ]
Synopsis: The structures of the commensurate 1/4 and 1/5 phases of the displacively modulated compound D-BCCD [deuterated betaine (trimethylammonioacetate) calcium chloride dihydrate, i.e. (CD3)3NCD2COOCaCl2(D2O)2 or CaCl2.C5D11NO2.2D2O] have been determined by single-crystal neutron diffraction at 100 and 68 K, respectively. The structural model of the 1/4 phase is found to be quite different from that obtained previously from X-ray diffraction data of the hydrogenated compound.
Formula: CaCl2C5D11NO22D2O at 100 and 68 K
Acta Cryst. (1999). C55, 1466-1470 [ doi:10.1107/S0108270199006812 ]
-Me-N,N'-bis(salicylidene)butane-2,3-diaminato]bis(pyridine)cobalt(III) tetrafluoroborate hydrateFormula: [Co(C20H22N2O2)(C5H5N)2]BF4xH2O, with x = 1.5 and 1.7
Acta Cryst. (1999). C55, 1470-1472 [ doi:10.1107/S0108270199006848 ]
Formula: [Zn2(C4H2O4)2(C10H8N2)2(H2O)2]2H2O
Acta Cryst. (1999). C55, 1472-1475 [ doi:10.1107/S0108270199006915 ]
-methacrylato-O:O'-bis[(1,10-phenanthroline-N,N')bis(methacrylato-O,O')ytterbium(III)]Formula: [Yb2(C4H5O2)6(C12H8N2)2]
Acta Cryst. (1999). C55, 1475-1479 [ doi:10.1107/S0108270199007313 ]
6-phenyl)alkylidene]-
-D-glucopyranosidesFormula: Four Cr(CO)3-alpha-D-glucopyranoside complexes
Acta Cryst. (1999). C55, 1479-1482 [ doi:10.1107/S0108270199007556 ]
Formula: (C8H11N4S)2[Th(NO3)6]4CH4O
Acta Cryst. (1999). C55, 1482-1483 [ doi:10.1107/S0108270199007143 ]
5-pentamethylcyclopentadienyl)uranium(IV)Formula: [UCl(C10H15)2(C6H5ClN)]
Acta Cryst. (1999). C55, 1483-1485 [ doi:10.1107/S0108270199006563 ]
-6-chloropyridin-2-olato)methoxydiruthenium(II, III)Formula: [Ru2(C5H3ClNO)4(CH3O)]
Acta Cryst. (1999). C55, 1486-1489 [ doi:10.1107/S0108270199006356 ]
Formula: C13H15N2+C8H5O5-
Acta Cryst. (1999). C55, 1489-1492 [ doi:10.1107/S0108270199006319 ]
![[bold pi]](/logos/entities/pi_bdgif.gif)

stacking
interactionsFormula: 2C7H6O43C10H8N2
Acta Cryst. (1999). C55, 1492-1494 [ doi:10.1107/S010827019900654X ]
Formula: C6H10N4
Acta Cryst. (1999). C55, 1494-1496 [ doi:10.1107/S010827019900671X ]
Formula: C18H30N85H2O
Acta Cryst. (1999). C55, 1496-1499 [ doi:10.1107/S0108270199007891 ]
O interactions in dimethyl 6,6'-dimethoxy-3,3',5,5'-tetramethylbiphenyl-2,2'-dicarboxylateFormula: C22H26O6
Acta Cryst. (1999). C55, 1499-1503 [ doi:10.1107/S0108270199006885 ]
X interactions in two triclinic phases of 4-carboxyquinolinium chloride
monohydrateFormula: C10H8NO2+Cl-H2O
Acta Cryst. (1999). C55, 1503-1506 [ doi:10.1107/S0108270199007684 ]
Formula: 2C12H9N2+I2Cl-ICl2-
Acta Cryst. (1999). C55, 1506-1508 [ doi:10.1107/S0108270199007775 ]
Formula: C12H10N22+ICl2-Cl-
Acta Cryst. (1999). C55, 1508-1511 [ doi:10.1107/S0108270199007192 ]
Formula: C23H26N2O22H2O
Acta Cryst. (1999). C55, 1511-1512 [ doi:10.1107/S0108270199006095 ]
Formula: C15H11Cl2NO
Acta Cryst. (1999). C55, 1513-1514 [ doi:10.1107/S0108270199006149 ]
Formula: C17H21NO2
Acta Cryst. (1999). C55, 1515-1517 [ doi:10.1107/S0108270199006393 ]
Formula: C17H22O3 and C23H25NO5
Acta Cryst. (1999). C55, 1517-1519 [ doi:10.1107/S0108270199008021 ]
Formula: C24H18O5S2
Acta Cryst. (1999). C55, 1519-1522 [ doi:10.1107/S0108270199007003 ]
Formula: C15H17ClO3 and C19H23ClO3
Acta Cryst. (1999). C55, 1522-1524 [ doi:10.1107/S0108270199005879 ]

(phenyl) and intermolecular C-H
(phenyl) interactions in
5-amino-4-(4-methoxyphenyl)-2-phenyl-7-piperidino-1,6-naphthyridine-8-carbonitrile--benzene(2/1)Formula: C27H25N5O0.5C6H6
Acta Cryst. (1999). C55, 1525-1526 [ doi:10.1107/S0108270199006435 ]
Formula: C12H19ClNPS
Acta Cryst. (1999). C55, 1526-1528 [ doi:10.1107/S0108270199007908 ]
Formula: C13H8N6
Acta Cryst. (1999). C55, 1528-1530 [ doi:10.1107/S0108270199006897 ]
Formula: C26H24N4O
Acta Cryst. (1999). C55, 1530-1533 [ doi:10.1107/S0108270199006290 ]
Formula: C25H20OC18H15OP
Acta Cryst. (1999). C55, 1533-1534 [ doi:10.1107/S0108270199006459 ]
-D-mannofuranosyl)-N,N-(pentamethylene)ethanethioamideFormula: C19H31NO5S
Acta Cryst. (1999). C55, 1535-1536 [ doi:10.1107/S0108270199007635 ]
Formula: 2N2H5+C10H4N2O62-
Acta Cryst. (1999). C55, 1536-1538 [ doi:10.1107/S0108270199006824 ]
Formula: C5H5NOS
Acta Cryst. (1999). C55, 1538-1540 [ doi:10.1107/S0108270199007039 ]
Formula: C20H32N6O12S28H2O
Acta Cryst. (1999). C55, 1541-1542 [ doi:10.1107/S0108270199007210 ]
-D-xylofuranosylamineFormula: C15H21NO7
Acta Cryst. (1999). C55, 1542-1545 [ doi:10.1107/S0108270199006381 ]
Formula: C8H16O42C4H9N3S
Acta Cryst. (1999). C55, 1545-1547 [ doi:10.1107/S010827019900685X ]
Formula: C31H32N4O4S2
Acta Cryst. (1999). C55, 1547-1555 [ doi:10.1107/S0108270199006162 ]
Formula: Seven 1:1 complexes of L- and D-amino acids
Acta Cryst. (1999). C55, 1556-1559 [ doi:10.1107/S0108270199006289 ]
O interactions in bis(8-dimethylamino-1-dimethylammonionaphthalene) [(DMANH+)2] 4,8-dicarboxynaphthalene-1,5-dicarboxylate dihydrateFormula: 2C14H19N2+C14H6O82-2H2O
Acta Cryst. (1999). C55, 1560-1562 [ doi:10.1107/S0108270199006538 ]
-D-ribofuranosyl)-7-iodo-7-deazaadenineFormula: C11H13IN4O3
Acta Cryst. (1999). C55, 1562-1565 [ doi:10.1107/S0108270199005880 ]
Formula: C6H7ClN4O5 und C11H17ClN4O3
Acta Cryst. (1999). C55, 1565-1567 [ doi:10.1107/S0108270199006320 ]
Formula: C9H7N
Acta Cryst. (1999). C55, 1568-1570 [ doi:10.1107/S0108270199006472 ]
Formula: C7H9N50.5C2I4
Acta Cryst. (1999). C55, 1570-1572 [ doi:10.1107/S0108270199006770 ]
,4
-diyl diacetateFormula: C31H50O4
Acta Cryst. (1999). C55, 1572-1573 [ doi:10.1107/S0108270199008033 ]
Formula: C18H15Se+I-
Acta Cryst. (1999). C55, 1574-1575 [ doi:10.1107/S0108270199006976 ]
Formula: C34H32O6
Acta Cryst. (1999). C55, 1575-1577 [ doi:10.1107/S0108270199005260 ]
Formula: C24H33N3O6
Acta Cryst. (1999). C55, 1577-1579 [ doi:10.1107/S0108270199006964 ]
Formula: C14H10Cl4Te
Acta Cryst. (1999). C55, 1579-1581 [ doi:10.1107/S0108270199006575 ]
Formula: C28H23N3O
Acta Cryst. (1999). C55, 1581-1583 [ doi:10.1107/S0108270199006307 ]
Formula: C19H18P+C3H13B10S-
Acta Cryst. (1999). C55, 1583-1585 [ doi:10.1107/S0108270199007672 ]
Formula: C19H17N2+NO3-
Acta Cryst. (1999). C55, 1585-1587 [ doi:10.1107/S010827019900640X ]
Formula: C7H9N5O3H2O
Acta Cryst. (1999). C55, 1587-1589 [ doi:10.1107/S0108270199006873 ]
Formula: C20H29NO3S
Acta Cryst. (1999). C55, 1589-1591 [ doi:10.1107/S0108270199007246 ]
Formula: C3H12N22+2ClO4-
Acta Cryst. (1999). C55, 1591-1593 [ doi:10.1107/S0108270199006782 ]
Formula: C16H10O4
Acta Cryst. (1999). C55, 1593-1595 [ doi:10.1107/S010827019900788X ]
Formula: C24H30O4 and C14H18O4
Acta Cryst. (1999). C55, 1595-1598 [ doi:10.1107/S0108270199006101 ]
Formula: C15H22O2 at 135 and 294 K
Acta Cryst. (1999). C55, 1598-1599 [ doi:10.1107/S0108270198016436 ]
-glutamylcysteine synthetaseFormula: C9H16N2O4S
Acta Cryst. (1999). C55, 1600-1605 [ doi:10.1107/S0108270199007428 ]
-keto acid in its enantiomeric and racemic forms and
enantiomeric disordering in the racemateFormula: (+)- and (+/-)-C10H14O3
Acta Cryst. (1999). C55, 1605-1607 [ doi:10.1107/S0108270199006253 ]
Formula: C18H25NO4S
Acta Cryst. (1999). C55, 1607-1610 [ doi:10.1107/S0108270199007544 ]
N and C-H
O interactions from one-dimensional
chains comprising the two independent molecues of N,N'-dicyclohexyl-N-nicotinoylureaFormula: C19H27N3O2
Copyright © International Union of Crystallography
IUCr Webmaster